Drug combinations for treatment of mice infected with acyclovir-resistant herpes simplex virus.

le Schinazi, R F
Foilsithe 1987

Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.

le Eriksson, B F, Schinazi, R F
Foilsithe 1989

HCV drug discovery aimed at viral eradication

le Schinazi, R. F., Bassit, L., Gavegnano, C.
Foilsithe 2009

Comparison of inhibitory activities of various antiretroviral agents against particle-derived and recombinant human immunodeficiency virus type 1 reverse transcriptases.

le Schinazi, R F, Eriksson, B F, Hughes, S H
Foilsithe 1989

Phosphorylation of 3'-azido-2',3'-dideoxyuridine and preferential inhibition of human and simian immunodeficiency virus reverse transcriptases by its 5'-triphosphate.

le Eriksson, B F, Chu, C K, Schinazi, R F
Foilsithe 1989

Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells.

le Cui, L, Yoon, S, Schinazi, R F, Sommadossi, J P
Foilsithe 1995

Inhibition of B Virus (Macacine herpesvirus 1) by Conventional and Experimental Antiviral Compounds

le Krug, P. W., Schinazi, R. F., Hilliard, J. K.
Foilsithe 2010

Pharmacokinetics of a water-soluble fullerene in rats.

le Rajagopalan, P, Wudl, F, Schinazi, R F, Boudinot, F D
Foilsithe 1996

Uridine reverses the toxicity of 3'-azido-3'-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activity.

le Sommadossi, J P, Carlisle, R, Schinazi, R F, Zhou, Z
Foilsithe 1988

Infectious amplification of wild-type human immunodeficiency virus from patients' lymphocytes and modulation by reverse transcriptase inhibitors in vitro.

le Mathez, D, Schinazi, R F, Liotta, D C, Leibowitch, J
Foilsithe 1993

Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracere...

le Schinazi, R F, Peters, J, Sokol, M K, Nahmias, A J
Foilsithe 1983

Structure-activity relationships and mode of action of 5-mercapto-substituted oligo- and polynucleotides as antitemplates inhibiting replication of human immunodeficiency virus typ...

le Bardos, T J, Schinazi, R F, Ling, K H, Heider, A R
Foilsithe 1992

Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rats.

le Boudinot, F D, Smith, S G, Funderburg, E D, Schinazi, R F
Foilsithe 1991

Antiviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase occur in specific RNA structural regions.

le Schinazi, R F, Lloyd, R M, Ramanathan, C S, Taylor, E W
Foilsithe 1994

Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intrac...

le Schinazi, R F, Fox, J J, Watanabe, K A, Nahmias, A J
Foilsithe 1986

Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.

le Schinazi, R F, Scott, R T, Peters, J, Rice, V, Nahmias, A J
Foilsithe 1985

Combinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1.

le Schinazi, R F, Cannon, D L, Arnold, B H, Martino-Saltzman, D
Foilsithe 1988

Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene.

le Schinazi, R F, Sijbesma, R, Srdanov, G, Hill, C L, Wudl, F
Foilsithe 1993

Correlation between preferred sugar ring conformation and activity of nucleoside analogues against human immunodeficiency virus.

le Van Roey, P, Salerno, J M, Chu, C K, Schinazi, R F
Foilsithe 1989

Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rhesus monkeys.

le Schinazi, R F, Boudinot, F D, Doshi, K J, McClure, H M
Foilsithe 1990